Novonix Limited closed the sale of its NOVONIX Battery Technology Solutions Inc. (BTS) business on April 30 2026. The transaction, valued at a nominal $1.00, transferred the BTS assets to former CEO Dr. Chris Burns, who will operate the former division as two independent companies: Avrion Battery Labs Inc., which will provide advanced battery testing systems, and Dryve Battery Materials Inc., which will pursue a dry‑synthesis platform for lithium‑ion cathode materials. Novonix retains a 15 % equity stake in Dryve, giving it a residual interest in the new cathode‑material venture.
The divestiture removes Novonix’s only revenue‑generating unit, leaving the company with a single product focus on synthetic graphite anodes. Management says the move is part of a disciplined strategy to build a vertically integrated synthetic graphite supply chain in North America and to concentrate capital and management attention on the anode business. The sale frees resources that can be deployed toward the Chattanooga, Tennessee, production facility and the planned Enterprise South expansion, which together are expected to bring total synthetic‑graphite capacity to over 50,000 tpa by 2028.
Financially, Novonix had a cash balance of $57.1 million as of March 31 2026, providing roughly four quarters of funding based on recent cash usage. The company also has a conditional $754 million Department of Energy loan commitment expected to close in the first half of 2026. The nominal sale price of $1.00 reflects the strategic nature of the transaction, while the retained 15 % stake in Dryve provides a potential upside if the dry‑synthesis platform succeeds.
CEO Mike O'Kronley said, "The divestiture of the BTS division reflects our disciplined strategy of building a vertically integrated synthetic graphite supply chain in North America." He added that by shedding non‑core business segments, the company is directing its management attention and capital toward advancing domestic supply of this critical mineral and supporting the growth of the North American battery industry.
Investors responded positively to the clarity of Novonix’s strategic focus. The divestiture removes ambiguity about the company’s revenue mix and signals a commitment to scaling its synthetic‑graphite anode business, which is expected to drive future growth as offtake agreements with major battery manufacturers are pursued.
The sale changes Novonix’s risk profile by eliminating the revenue‑generating BTS unit, making the company’s financial performance fully dependent on the success of its synthetic‑graphite anode operations. The retained equity stake in Dryve provides a potential upside if the dry‑synthesis cathode platform gains traction, while the freed capital can accelerate the Chattanooga and Enterprise South projects, positioning Novonix to capture a larger share of the growing North American battery‑material market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.